These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 17147974)

  • 1. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
    Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
    Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against non-NMDA receptor-mediated excitotoxicity by GYKI 52466 in mature telencephalic cultures of the rat.
    Kovács AD; Egyed A
    Neurobiology (Bp); 1996; 4(1-2):59-72. PubMed ID: 9116695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity.
    Donevan SD; Yamaguchi S; Rogawski MA
    J Pharmacol Exp Ther; 1994 Oct; 271(1):25-9. PubMed ID: 7525924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimetazidine modulates AMPA/kainate receptors in rat vestibular ganglion neurons.
    Dayanithi G; Desmadryl G; Travo C; Chabbert C; Sans A
    Eur J Pharmacol; 2007 Nov; 574(1):8-14. PubMed ID: 17658512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cobalt accumulation in neurons expressing ionotropic excitatory amino acid receptors in young rat spinal cord: morphology and distribution.
    Nagy I; Woolf CJ; Dray A; Urbán L
    J Comp Neurol; 1994 Jun; 344(3):321-35. PubMed ID: 8063957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
    Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death.
    Seo SY; Yun BS; Ryoo IJ; Choi JS; Joo CK; Chang SY; Chung JM; Oh S; Gwag BJ; Yoo ID
    J Pharmacol Exp Ther; 2001 Oct; 299(1):377-84. PubMed ID: 11561102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology.
    Verdoorn TA; Dingledine R
    Mol Pharmacol; 1988 Sep; 34(3):298-307. PubMed ID: 2901662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models.
    Gigler G; Móricz K; Agoston M; Simó A; Albert M; Benedek A; Kapus G; Kertész S; Vegh M; Barkóczy J; Markó B; Szabó G; Matucz E; Gacsályi I; Lévay G; Hársing LG; Szénási G
    Br J Pharmacol; 2007 Sep; 152(1):151-60. PubMed ID: 17603549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization, localization, and regulation of ionotropic glutamate receptors in skate horizontal cells.
    Kreitzer MA; Birnbaum AD; Qian H; Malchow RP
    Vis Neurosci; 2009; 26(4):375-87. PubMed ID: 19678977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
    Johansen TH; Chaudhary A; Verdoorn TA
    Mol Pharmacol; 1995 Nov; 48(5):946-55. PubMed ID: 7476926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca(2+) influx through AMPA or kainate receptors alone is sufficient to initiate excitotoxicity in cultured oligodendrocytes.
    Alberdi E; Sánchez-Gómez MV; Marino A; Matute C
    Neurobiol Dis; 2002 Mar; 9(2):234-43. PubMed ID: 11895374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the antagonist actions of (RS)-2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl] propionic acid (ATPO) on non-NMDA receptors in cultured rat neurones.
    Dai WM; Ebert B; Madsen U; Lambert JD
    Br J Pharmacol; 1998 Dec; 125(7):1517-28. PubMed ID: 9884081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines.
    Wilding TJ; Huettner JE
    Mol Pharmacol; 1995 Mar; 47(3):582-7. PubMed ID: 7700255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of AMPA/kainate-excitotoxicity in MK801-induced neuronal death in the retrosplenial cortex.
    Bender C; Rassetto M; de Olmos JS; de Olmos S; Lorenzo A
    Neuroscience; 2010 Aug; 169(2):720-32. PubMed ID: 20457221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evans blue antagonizes both alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate receptors and modulates receptor desensitization.
    Price CJ; Raymond LA
    Mol Pharmacol; 1996 Dec; 50(6):1665-71. PubMed ID: 8967991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
    J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation of glutamatergic transmission by 3,5-dibromo-L-phenylalanine.
    Yarotskyy V; Glushakov AV; Sumners C; Gravenstein N; Dennis DM; Seubert CN; Martynyuk AE
    Mol Pharmacol; 2005 May; 67(5):1648-54. PubMed ID: 15687225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors mediate development, but not maintenance, of secondary allodynia evoked by first-degree burn in the rat.
    Jones TL; Sorkin LS
    J Pharmacol Exp Ther; 2004 Jul; 310(1):223-9. PubMed ID: 15007101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo.
    Weiss B; Alt A; Ogden AM; Gates M; Dieckman DK; Clemens-Smith A; Ho KH; Jarvie K; Rizkalla G; Wright RA; Calligaro DO; Schoepp D; Mattiuz EL; Stratford RE; Johnson B; Salhoff C; Katofiasc M; Phebus LA; Schenck K; Cohen M; Filla SA; Ornstein PL; Johnson KW; Bleakman D
    J Pharmacol Exp Ther; 2006 Aug; 318(2):772-81. PubMed ID: 16690725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.